mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4,000 Liter Single-Use Bioreactor Press Releases Read more March 23, 2021/0 Comments/by Paige Ehrl http://cn.abec.com/wp-content/uploads/2019/04/ABEC-logo_CN-01.png 0 0 Paige Ehrl http://cn.abec.com/wp-content/uploads/2019/04/ABEC-logo_CN-01.png Paige Ehrl2021-03-23 14:08:502021-04-09 15:27:28mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4,000 Liter Single-Use Bioreactor
